Textile slow-release systems with medical applications

• Autorzy: ten Breteler M. R. , Nierstrasz V. A. , Warmoeskerken M. M. C. G.
• Języki publikacji: EN

Abstrakty

EN

In the development of medical drug delivery systems, attention has been increasingly focused on slow- or controlled delivery systems in order to achieve an optimal therapeutic effect. Since the administration of drugs often requires a defined or minimum effective dosage in the human body, more conventional delivery systems such as tablets require relatively high doses, which can result in undesired toxic effects. Subsequent degradation of the drug in the human body will result in a drug concentration below the minimum effective level. Furthermore, there are situations where oral administration is less advisable, such as in cases of prolonged treatment or with people that are forgetful, which again results in ineffective treatment. Textile slow-release systems have the potential to overcome these negative aspects. Drugs containing transdermal patches for ex-vivo applications are already familiar; however, this paper will not deal with such applications, but with more advanced in-vivo textile slow-release systems. Due to enormous progress over the years in the fields of supramolecular chemistry, nanotechnology, and polymer science & technology, a number of promising drug delivery technologies have been developed. This review will focus on the opportunities of textiles bearing cyclodextrins, aza-crown ethers or fullerenes, as well as ion-exchange fibres, drug-loaded hollow fibres, textiles treated with nanoparticles and fibres with bioactive compounds in their embodiment. In this paper, the delivery systems will be discussed and compared in terms of biostability, biodegradability, controllability, toxicity, carcinogenicity, interface reactions, material costs and the fabrication process.

Słowa kluczowe

EN

slow release; drug delivery; medical; cyclodextrin; crown ethers; fullerenes; ion-exchange fibres; follow fibres; nanoparticles; entrapment; encapsulation

PL

powolne uwalnianie; podawanie leku; cyklodekstryny; etery koronowe; fulereny; włókna jonowymienne; nanocząstka; hermetyzacja

• Wydawca: Lodz University of Technology, Faculty of Material Technologies and Textile Design
• Czasopismo: Autex Research Journal
• Rocznik: 2002
• Tom: Vol. 2, no. 4
• Strony: 175--189
• Opis fizyczny: Bibliogr. 29 poz.

Twórcy

autor

ten Breteler M. R.

• Department of Chemical Technology, University of Twente, P.O. Box 217 7500 AE Enschede The Netherlands

autor

Nierstrasz V. A.

• Department of Chemical Technology, University of Twente, P.O. Box 217 7500 AE Enschede The Netherlands

autor

Warmoeskerken M. M. C. G.

• Department of Chemical Technology, University of Twente, P.O. Box 217 7500 AE Enschede The Netherlands

Bibliografia

• 1. Schollmeyer, E., Buschmann, H.-J. German Patent DE 19810951A1, 1999.
• 2. Jaskari, T., Vuorio, M., Kontturi, K., Urtti, A., Manzanares, J.A., Hirvonen, J. Controlled transdermal iontophoresis by ion-exchange fibre. J. Control. Rel. 67, (2000) pp 179-190.
• 3. Loftsson, T., Brewster, M.E. Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilisation and Stabilization. J. Pharm. Sci. 85, (1996) pp 1017-1025.
• 4. Hirayama, F., Uekama, K. Cyclodextrin-based controlled drug release system. Adv. Drug Del. Rev. 36 (1999) 125-141.
• 5. Denter, U., Buschmann, H.-J., Knittel, D., Schollmeyer, E. Modifizierung von Faseroberflachen durch die permanente Fixierung supramolekularer Komponenten, Teil 2: Cyclodextrin. Angew. Makromol. Chem. 248, (1997) pp 165-188.
• 6. Poukalis, K., Buschmann, H.-J., Schollmeyer, E. German Patent DE 4035378 A1, 1992.
• 7. Buschmann, H.-J., Knittel, D., Schollmeyer, E. New Textile Applications of Cyclodextrins. J. Inclusion Phenom. Macro. Chem. 40, (2001) pp 169-172.
• 8. Denter, U., Schollmeyer, E. Surface Modification of Synthetic and Natural Fibres by Fixation of Cyclodextrin Derivatives. J. Inclusion Phenom. Mol. Recog. Chem. 25, (1996) pp 197-202.
• 9. Denter, U., Buschmann, H.-J., Schollmeyer, E. Modifizierung von Faseroberflachen durch permanente Fixierung supramolekularer Komponenten, Teil 3: Azakronether. Angew. Makromol Chem. 258, (1998) pp 75-81.
• 10. Denter, U., Buschmann, H.-J., Schollmeyer, E. Modifizierung von Faseroberflachen durch die permanente Fixierung supramolekularer Komponenten, Teil 4: Fullerenen C60. Angew. Makromol. Chem. 258, (1998) pp 87-91.
• 11. Jaskari, T., Vuorio, M., Kontturi, K., Manzanares, J.A., Hirvonen, J. Ion-exchange fibres and drugs: an equilibrium study. J. Control. Rel. 70. (2001) pp 219-229.
• 12. Jarnstrom, R., Hirvonen, J. US Patent, US 6,254,883, 2001.
• 13. Skundric, P., Medovic, A., Kostic, M., Kljajic, Lj. Fibrous Systems With Biological Activity For Diabetes Treatment - Cationexchange Pan Fibres Based Artificial Store of Insulin. Proceedings of the 2nd AUTEX Conference, Textile Engineering at the dawn of a new millennium: an exciting challenge, Bruges, Belgium 1-3 July 2002 pp 377-384.
• 14. Skundric, P., Medovic, A., Kostic., M. Fibrous Systems With Programmed Biological-Activity and Their Application In Medical Practice. AUTEX Research Journal 2, (2002) pp 78-84.
• 15. Ostad, S.N., Malhi, J.S., Gard, P.R. In-vitro cytotoxicity and teratogenicity of norethisterone and levonorgestrel released from hollow nylon monofilaments. J. Control. Rel. 50, (1998) pp 179-186.
• 16. Anand, V., Kandarapu, R., Garg, S. Ion-exchange resins: carrying drug delivery forward. DDT 6, (2001) pp 905-914.
• 17. Van Laarhoven, J.A.H., Kruft, M.A.B., Vromans, H. In-vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring. Int. J. Pharm. 232, (2002) pp 163-173.
• 18. Soane, D.S., Osford, D.A., Ware, W. Jr., Linford, M.R., Green, E., Lau, R. Worldwide Patent, WO 0106054 A1, 2001.
• 19. Wheatley, M.A., Ko, F.K., El-Sherif, D., Dhoot, N., Kanakasabai, S., Benjelloun, M., Han, B. Worldwide Patent WO 0200149 A1, 2002.
• 20. Woo, G.L.Y., Mittelman, M.W., Santerre, J.P. Synthesis and characterisation of a novel biodegradable antimicrobial polymer. Biomat. 21, (2000) pp 1235-1246.
• 21. Szejtli, J., Osa, T. (Eds). Comprehensive Supramolecular Chemistry. Vol. 3: Cyclodextrins. Pergamon - Elsevier Science Ltd, Oxford, 1996.
• 22. Rouette, H.K. Encyclopedia of Textile Finishing. Springer-Verlag, Berlin-Heidelberg, 2001.
• 23. Bradshaw, J.S., Krakowiak, K.W., Izatt, R.M. Heterocyclic Compounds Vol. 51: Aza-Crown Macrocycles. John Wiley & Sons, Inc., New York, 1993.
• 24. Murthy, C.N., Geckeler, K.E. The water-soluble fi-cyclodextrin-[60]fullerene complex. CHEMCOMM Comm. (2001) pp 1194-1195.
• 25. Samal, S., Geckeler, K.E. Cyclodextrin-fullerenes: a new class of water-soluble fullerenes CHEMCOMM Comm. (2000) pp 1101-1102.
• 26. Stella, V.J., Rao, V.M., Zannou, E.A., Zia, V. Mechanisms of drug release from cyclodextrin complexes. Adv. Drug Del. Rev. 36, (1999) pp 3-16.
• 27. Ramraj, R., Farrell, S., Loney, N.W. Mathematical modelling of controlled release from a hollow fibre. J. Mem. Sci. 162, (1999) pp 73-81.
• 28. Farrell, S., Sirkar, K.K. A mathematical model of an aqueous-organic partition-based controlled release system using microporous membranes. J. Control. Rel. 61, (1999) pp 345-360.
• 29. Farrell, S., Sirkar, K.K. Mathematical model of a hybrid dispersed network-membrane-based controlled release system. J. Control. Rel. 70, (2001) pp 51-61.